Tomas Andersson MD, PhD

Dr Tomas Andersson, MD PhD, Vice President Cardiovascular and Chronic Kidney Disease, AstraZeneca, Gothenburg, Sweden. Dr Andersson is a physician, specialist in Clinical Pharmacology and has a long-standing interest and expertize of cardiovascular and respiratory late phase drug development. He has led several clinical drug projects from design until registrational approval globally. He is also interested in exploring new ways of conducting clinical research, such as using registries and electronic healthcare records.